Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 4 1

Status

Completed 2Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 16Breast 13Other 8Genitourinary 6Lymphoid 5Other hematologic neoplasm 4Gynecologic 4Thoracic 3Endocrine 3Tumor-Agnostic 2Myeloid 1Head & Neck 1Dermatologic 1CNS 1

Conditions

Obesity 3Multiple Endocrine Neoplasia Type 1 3Sexual Dysfunction, Physiological 1Overweight 1Motor Activity 1Inflammation 1

Interventions

Everolimus 61lutetium Lu 177 dotatate 53Magnetic Resonance Spectroscopy 39pembrolizumab 31Temozolomide 31Cisplatin 29Nivolumab 26Octreotide 25lanreotide 24gallium Ga 68 dotatate 24cabozantinib 22pasireotide 21lenvatinib 203-Iodobenzylguanidine 20Etoposide 19Sunitinib 18Specimen Handling 18Paclitaxel 18Carboplatin 18Capecitabine 18surufatinib 16Bevacizumab 16trametinib 15dabrafenib 15Sorafenib 14Doxorubicin 14Ipilimumab 13Thyrotropin Alfa 12Surgical Procedures, Operative 12Injections 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Diet × Endocrine × Clear all
NCT04175678 2026-03-10

Project 1: Diet and Exercise Modulate the Sperm Epigenome in Men

Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center

Phase NA Active not recruiting
100 enrolled
EndocrineOther

Motor Activity, Obesity, Multiple Endocrine Neoplasia Type 1

NCT01554735 2015-07-29

Effects of Lifestyle-modification Induced Weight Loss on Sexual and Urinary Function, and Quality of Life in Obese Men

Changi General Hospital

Phase 4 Completed
70 enrolled
EndocrineOther

Inflammation, Obesity, Sexual Dysfunction, Physiological, Multiple Endocrine Neoplasia Type 1

NCT00412633 2012-06-11

Clinical & Web-based Diet & Activity Counseling for Men

University of California, San Diego

Phase NA Completed
442 enrolled
EndocrineOther

Obesity, Multiple Endocrine Neoplasia Type 1, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon âš¡